OTC deals hit unprecedented high

OTC deals hit unprecedented high


19 March 2015 - Deborah Wilkes


The 'OTC Deal Trends 2015' Briefing provides a concise analysis of recent acquisitions, mergers and joint ventures in the global consumer healthcare industry.

Analysis of around 60 OTC deals in 2014 revealed 10 key trends:

  • Mega OTC deals reshaped the global OTC industry
  • Vitamins, minerals and supplements (VMS) attracted a variety of acquirers
  • Food companies raced into sports nutrition
  • Interesting deals emerged in the skin treatments category
  • Emerging markets appealed to acquirers
  • Generics companies remained keen to build an OTC presence
  • Private-equity firms snapped up OTC assets
  • Spin-offs hit the headlines
  • OTC assets changed hands as part of wider pharmaceutical deals
  • Portfolio streamlining released OTC brands

2014 was a momentous year for the OTC industry. GlaxoSmithKline has created a joint venture with Novartis, Bayer has acquired Merck & Co's Consumer Care business, and Perrigo is purchasing Omega Pharma. It was also a bumper year for all sorts of OTC deals.

This authoritative Briefing from OTCToolbox helps put this deal-making activity in context.

The Briefing is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.

It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people with an Annual Subscription to the OTCToolbox website.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Briefings

Share this page: